If you are on Mounjaro 5 mg and wondering whether you need to move up before you see results, the answer fits in one number: in the SURMOUNT-1 trial, this dose produced 15.0% body weight loss at 72 weeks, roughly 72% of what the maximum dose achieves. Most of the effect is already there. Note that in the United States the same molecule is sold as Zepbound 5 mg for weight management, and everything below applies equally. This article covers what to expect at this dose in percentages and pounds, what moving up to the next step actually adds — considerably less than most people assume — and why staying on Mounjaro 5 mg is, in some situations, the better call. Escalation is your doctor’s decision; this prepares that conversation rather than replacing it.
How much weight loss to expect on Mounjaro 5 mg
In SURMOUNT-1, Mounjaro 5 mg produced 15.0% body weight loss at 72 weeks on the treatment-regimen estimand, and 16.0% on the efficacy estimand. At 15 mg, the highest dose, loss reached about 20.9%. Mounjaro 5 mg therefore delivers roughly 72% of the effect of the maximum dose.
A word on those two ways of counting, since both figures circulate. The treatment-regimen estimand measures loss across everyone who started the trial, including those who stopped; the efficacy estimand measures it among those who actually stayed on treatment. The second always gives a higher number. Both are accurate; they simply answer different questions. These results come from SURMOUNT-1, published in the New England Journal of Medicine.
That 72% figure is what separates Mounjaro 5 mg from its reputation. This dose is almost universally treated as a stepping stone, something to endure before reaching “the real dose”. The data describe something else: a therapeutic dose in its own right, already delivering most of the result.
What Mounjaro 5 mg means in pounds
A percentage stays abstract until you apply it to your own weight. Here is what 15.0% on Mounjaro 5 mg works out to by starting weight. These are trial averages, not guaranteed individual results.
| Starting weight | Expected loss on Mounjaro 5 mg (−15.0%) |
|---|---|
| 176 lb (80 kg) | about 26 lb (12 kg) |
| 198 lb (90 kg) | about 30 lb (13.5 kg) |
| 220 lb (100 kg) | about 33 lb (15 kg) |
| 243 lb (110 kg) | about 36 lb (16.5 kg) |
To place your own starting point and trajectory, you can check your BMI and weight-loss projection.
Should you move up beyond Mounjaro 5 mg?
Escalation pays, but less and less. Moving from Mounjaro 5 mg to 10 mg adds 4.5 percentage points of loss. Moving from 10 to 15 mg adds only 1.4. Most of the benefit of escalation is on the first step.
| Step | Additional gain |
|---|---|
| Mounjaro 5 mg to 10 mg | +4.5 points |
| 10 mg to 15 mg | +1.4 points |
The implication can be stated without deciding for your prescriber: the last step is bought at the cost of generally poorer tolerability, for a marginal gain. That does not mean nobody should move up — plenty of situations justify it, and that judgement belongs to your doctor. It means someone who stays on Mounjaro 5 mg because tolerability will not allow more is not failing at treatment.
Mounjaro 5 mg as a maintenance dose
Stepping back down to Mounjaro 5 mg after the weight-loss phase does not return you to the starting line. That is what the SURMOUNT-MAINTAIN trial, published in The Lancet, tested: on 5 mg maintenance, participants held a 16.6% loss, against 21.9% for those who stayed at the maximum dose.
The gap is real, around 5 points, but it should be read the right way round. Reducing the dose in maintenance is not accompanied by regain of the weight already lost: it preserves most of the benefit. That is useful information for anyone considering, with their doctor, easing a treatment for reasons of tolerability, cost or supply.
Tolerability on Mounjaro 5 mg
Mounjaro’s adverse effects are dominated by gastrointestinal symptoms — nausea, diarrhoea, constipation, vomiting — concentrated in the weeks following each dose increase. That is the key point: these effects attach to the change of step as much as to the step itself.
The corollary of the previous table is worth stating. Staying on Mounjaro 5 mg also means not exposing yourself to the increase in adverse effects associated with higher steps. The ratio between benefit obtained and tolerability is particularly favourable at this dose. We are not publishing rates by dose step here: those percentages do not appear in the sources we verified, and we do not quote figures without a source. The European product record for Mounjaro sets out the approved dose steps and the safety profile effect by effect.
How long should you stay on Mounjaro 5 mg?
There is no standard duration that applies to everyone. Time spent at each step depends on the prescribing protocol and on your individual tolerability; it is an appointment decision, not something to read off an article. We deliberately publish no schedule, no instruction to move up and no instruction to stay.
Three questions do help you prepare that appointment.
- Where am I relative to what is expected on Mounjaro 5 mg at this stage of treatment?
- Is escalation indicated in my situation, given my result and my tolerability?
- What signs would instead justify staying on Mounjaro 5 mg?
Frequently asked questions
Is Mounjaro 5 mg enough to lose weight?
In SURMOUNT-1, Mounjaro 5 mg produced 15.0% body weight loss at 72 weeks, roughly 72% of the effect of the maximum dose. That is a clinically meaningful loss. Whether this dose is “enough” in your case depends on your treatment goal and medical situation, which is a conversation for your doctor.
How much weight do you lose on Mounjaro 5 mg?
About 26 lb (12 kg) starting from 176 lb, and about 36 lb (16.5 kg) starting from 243 lb, applying the 15.0% observed at 72 weeks in SURMOUNT-1. These are population averages, not a guaranteed individual result.
Do you have to move up to 10 mg?
No, nothing is automatic: escalation is a medical decision that depends on your result, your tolerability and your situation. The data show that moving from Mounjaro 5 mg to 10 mg adds 4.5 points, while the next step adds only 1.4.
Can you stay on Mounjaro 5 mg long term?
SURMOUNT-MAINTAIN showed that reducing to 5 mg in maintenance held a 16.6% loss, against 21.9% at the maximum dose. Staying on or returning to Mounjaro 5 mg over time therefore does not erase the benefit already obtained. Treatment duration and dose level are matters for your prescriber.
What side effects occur at Mounjaro 5 mg?
Gastrointestinal effects dominate: nausea, diarrhoea, constipation, vomiting. They concentrate in the weeks after a dose increase, which is why a stable dose is often better tolerated than an escalation phase. The detail is in the European product record linked above.
Medical disclaimer. This article is strictly informational and does not replace medical advice. The figures cited are clinical trial averages and do not predict your individual result. The doses mentioned correspond to trial arms and constitute neither a dosing recommendation nor an escalation schedule: any decision to start, change or stop a treatment should be made with a healthcare professional. Information current as of 1 August 2026.
To track the effect on your own curve, logged data beats vague recollections on the day of your appointment: the MounjaGO app brings together weight, doses, side effects and meals, and turns them into a PDF report for your doctor — $12 for lifetime access, no subscription.